X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.business-standard.com/article/companies/astrazeneca-pharma-india-gets-nod-to-import-market-selumetinib-capsules-121092600914_1.html
https://www.business-standard.com/article/companies/astrazeneca-pharma-india-gets-nod-to-import-market-selumetinib-capsules-121092600914_1.html
https://www.astrazeneca.com/media-centre/press-releases/2021/selumetinib-recommended-for-eu-approval-in-nf1.html
https://www.astrazeneca.com/media-centre/press-releases/2020/selumetinib-granted-orphan-drug-designation-in-japan-for-neurofibromatosis-type-1.html
https://www.businesswire.com/news/home/20200413005139/en/KOSELUGO%E2%84%A2-selumetinib-Approved-Pediatric-Patients-Neurofibromatosis-Type
https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-children-debilitating-and-disfiguring-rare-disease
https://www.fiercepharma.com/pharma/astrazeneca-s-selumetinib-moves-past-cancer-failures-to-nab-fda-priority-review-rare
https://endpts.com/astrazeneca-merck-win-red-carpet-treatment-at-the-fda-for-a-3-time-loser/
https://www.prnewswire.com/news-releases/diverse-biotech-announces-appointment-of-new-chief-executive-officer-ceo--stella-vnook-300958378.html
https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2019/us-fda-accepts-regulatory-submission-for-selumetinib-in-neurofibromatosis-type-1-and-grants-priority-review-14112019.html
https://www.fiercebiotech.com/biotech/arcus-hires-ex-abbvie-genentech-researcher-as-cmo
http://www.pmlive.com/pharma_news/second_chance_for_astrazenecas_selumetinib_with_breakthrough_designation_1283047
https://www.businesswire.com/news/home/20190401005245/en/Selumetinib-Granted-Breakthrough-Therapy-Designation-Neurofibromatosis-Type/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.raps.org/news-and-articles/news-articles/2018/8/orphan-drug-regulations-in-europe?feed=Regulatory-Focus
http://www.pharmatimes.com/news/az_and_msd_get_orphan_designation_for_neurofibromatosis_drug_1246924
https://endpts.com/now-a-three-time-loser-selumetinib-continues-to-cause-headaches-as-astrazeneca-dumps-a-failed-phiii/
https://www.biospace.com/article/astrazeneca-s-cancer-drugs-mostly-soar-with-one-bomb-amidst-quarterly-report/
https://www.fiercebiotech.com/biotech/eurobiotech-report-astrazeneca-cancer-trial-gsk-attempts-r-d-turnaround-sanofi-digital
Market Place
Share 
